港股異動丨領展房產基金(0823.HK)漲3.72% 購入上海一商場50%權益
格隆匯2月25日丨入選了格隆匯2021年“下注中國”十大核心資產名單的領展房產基金(00823.HK)漲3.72%,報75.2港元,創近一年新高,總市值1555億港元。領展(00823.HK)昨日宣佈,以27.72億元人民幣收購位於上海的上海七寶萬科廣場之五成權益。收購價是基於該物業的議定物業價值64億元,較物業於2020年12月31日估值的65.8億元折讓2.7%。領展會以內部資金及融資安排支付這項收購,並擬局部對沖這項投資可能涉及的匯價波動。根據領展截至2020年9月30日的財務狀況,交易完成後,領展的備考經調整債務對資產總值比率將由17.9%上升至19.2%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.